NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus
500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic
urinary incontinence by an overactive bladder and the failure of anticholinergic drugs.